NCT03436420View on ClinicalTrials.gov

Gemcabene for the Treatment of Pediatric NAFLD

PHASE2TerminatedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

March 29, 2018

Primary Completion Date

August 27, 2019

Study Completion Date

August 27, 2019

Conditions

Non-Alcoholic Fatty Liver Disease

Interventions

DRUG

Gemcabene

Participants will take 300 milligrams (mg) of gemcabene, once per day for 12 weeks.

Trial Locations (1)

30322

Children's Healthcare of Atlanta / Emory University, Atlanta

Sponsors

Collaborators (1)

Gemphire Therapeutics

All Listed Sponsors

collaborator

Gemphire Therapeutics

INDUSTRY

lead

Emory University

OTHER